Form 8-K - Current report:
SEC Accession No. 0001437749-26-013638
Filing Date
2026-04-28
Accepted
2026-04-28 16:01:27
Documents
12
Period of Report
2026-04-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sava20260427_8k.htm   iXBRL 8-K 25524
  Complete submission text file 0001437749-26-013638.txt   155076

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA flna-20260422.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE flna-20260422_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE flna-20260422_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flna-20260422_pre.xml EX-101.PRE 11584
15 EXTRACTED XBRL INSTANCE DOCUMENT sava20260427_8k_htm.xml XML 2871
Mailing Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731
Business Address 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300 AUSTIN TX 78731 512-501-2444
FILANA THERAPEUTICS, INC. (Filer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41905 | Film No.: 26907468
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)